OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · Real-Time Price · USD
17.22
+0.14 (0.82%)
Feb 11, 2026, 4:00 PM EST - Market closed
OrthoPediatrics Stock Forecast
Stock Price Forecast
The 9 analysts that cover OrthoPediatrics stock have a consensus rating of "Strong Buy" and an average price target of $24.56, which forecasts a 42.62% increase in the stock price over the next year. The lowest target is $20 and the highest is $34.
Price Target: $24.56 (+42.62%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OrthoPediatrics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +33.57% | Jan 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +39.37% | Dec 10, 2025 |
| Needham | Needham | Strong Buy Maintains $42 → $26 | Strong Buy | Maintains | $42 → $26 | +50.99% | Oct 29, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +33.57% | Oct 29, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $37 → $34 | Strong Buy | Maintains | $37 → $34 | +97.44% | Oct 10, 2025 |
Financial Forecast
Revenue This Year
239.38M
from 204.73M
Increased by 16.93%
Revenue Next Year
268.70M
from 239.38M
Increased by 12.25%
EPS This Year
-1.61
from -1.64
EPS Next Year
-1.27
from -1.61
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 247.9M | 278.8M | ||
| Avg | 239.4M | 268.7M | ||
| Low | 228.8M | 256.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 21.1% | 16.5% | ||
| Avg | 16.9% | 12.2% | ||
| Low | 11.8% | 7.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.54 | -1.14 | ||
| Avg | -1.61 | -1.27 | ||
| Low | -1.69 | -1.46 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.